Febuxsostat as a renoprotector in patients with chronic renal insufficiency
In the article presented the data about dependence of uricemia's level and the subjective assessment of the quality of life in patients with end stage renal disease (ESRD) and an increase ofresidual functional renal reserve in 90 patients under the influence of febuxsostat at a dose of 40 mg ar...
Saved in:
Main Author: | Z. V. Babenko (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Febuxsostat as a renoprotector in patients with chronic renal insufficiency
by: Z. V. Babenko
Published: (2019) -
Efecto renoprotector de la eritropoyetina en modelos animales de daño renal. Revisión sistemática
by: Mónica Elena Fernández Jiménez, et al.
Published: (2023) -
Nefroprotective properties of febuxostat in chronic renal failure
by: Z. V. Babenko
Published: (2019) -
Nefroprotective properties of febuxostat in chronic renal failure
by: Z. V. Babenko
Published: (2019) -
Upper Digestive Endoscopic Findings in Patients with Chronic Renal Insufficiency in Phase of Dialysis
by: Marcos Félix Osorio Pagola, et al.
Published: (2009)